NTRK1 and neuroblastoma: However, the lack of Trk family mutations identified in neuroblastomas, despite intensive searches for genomic and transcriptomic alterations, suggests that Trk family expression may be altered by other pathways, for example dysregulation of upstream regulators such as the RUNX family.